Novartis has showcased its pipeline at its annual meet-the-management day, where investors and analysts got to hear company leaders give an overview of its drug pipeline.
AstraZeneca’s revival has continued with a third successive quarter of growth, as sales of new drugs for cancer and lung diseases outperformed the market’s expectations.
